JOHANNESBURG - Lenacapavir is described as a gamechanger in the fight against HIV/Aids.
The long-acting prevention injection only needs to be administered twice a year.
WATCH | HIV Treatment | Lifeline for underserved communities
The National AIDS Council and Health Department hosted a two-day roundtable this week, to discuss just that.
Dr Yogan Pillay, Global Director for HIV and TB Delivery at the Gates Foundation says the injection is expected to be in the country by the end of November.